Pharmacoeconomic study of the treatment of arterial hypertension in children and adolescents using cost-of-illness analysis
Background. The cost-of-illness (COI) analysis allows to estimate and plan costs for calculations between the subjects of the health care system and medical insurance organizations. The primary morbidity of the population with diseases of the circulatory system increased from 4,784 thousand people i...
Saved in:
Main Authors: | O. S. Mikhaylova (Author), A. V. Krikova (Author) |
---|---|
Format: | Book |
Published: |
IRBIS LLC,
2022-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PHARMACOECONOMIC STUDIES TREATMENT OF PATIENTS WITH INJURIES IN THE DEPARTMENT OF ANESTHESIOLOGY AND RESUSCITATION WITH METHODS ANALYSIS THE COST OF ILLNESS
by: Anton Alexandrovich Kasatkin
Published: (2015) -
Pharmacoeconomic justification of the choice of specific therapy schemes for the treatment of adult patients with pulmonary arterial hypertension
by: I. S. Datsenko, et al.
Published: (2022) -
Scientific substantiation of the concept of pharmacoeconomic analysis of technologies for early diagnosis and pharmacotherapy of pulmonary arterial hypertension
by: I. S. Datsenko, et al.
Published: (2022) -
Pharmacoeconomic analysis by the cost-minimization method of fluconazole drugs recommended for use in candidiosis
by: O. V. Tkachova, et al.
Published: (2020) -
PRELIMINARY RESULTS OF COMPARATIVE PHARMACOECONOMIC PROSPECTIVE STUDY OF DIFFERENT THERAPIES OF ARTERIAL HYPERTENSION
by: E. I. Tarlovskaya, et al.
Published: (2015)